Improving the American Drug Supply Chain Act of 2020
Sponsored By: Representative Hudson, Richard [R-NC-9]
Unknown
Summary
Improving the American Drug Supply Chain Act of 2020 This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) study the current and historical production of drugs and key ingredients in the United States and in foreign countries, and (2) formulate recommendations for promoting increased production of drugs and key ingredients in the United States.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Hudson, Richard [R-NC-9]
NC • R
Cosponsors
Sen. Blunt Rochester, Lisa [D-DE]
DE • D
Sponsored 10/13/2020
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov